Dr. Gregory Rosenfeld
Claim this profile(G.I.R.I.) GI Research Institute
Studies Crohn's Disease
Studies Ulcerative Colitis
7 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Gregory Rosenfeld is currently running
ABX464
for Ulcerative Colitis
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].
Recruiting1 award Phase 36 criteria
ABX464 Maintenance Therapy
for Ulcerative Colitis
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106.
Recruiting1 award Phase 3
More about Gregory Rosenfeld
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gregory Rosenfeld has experience with
- Mirikizumab
- ABX464
- 5-ASA Withdrawal
- Cx601
- Placebo
Breakdown of trials Gregory Rosenfeld has run
Crohn's Disease
Ulcerative Colitis
Psychogenic Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Rosenfeld specialize in?
Gregory Rosenfeld focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Gregory Rosenfeld currently recruiting for clinical trials?
Yes, Gregory Rosenfeld is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Gregory Rosenfeld has studied deeply?
Yes, Gregory Rosenfeld has studied treatments such as Mirikizumab, ABX464, 5-ASA Withdrawal.
What is the best way to schedule an appointment with Gregory Rosenfeld?
Apply for one of the trials that Gregory Rosenfeld is conducting.
What is the office address of Gregory Rosenfeld?
The office of Gregory Rosenfeld is located at: (G.I.R.I.) GI Research Institute, Vancouver, British Columbia V6Z 2K5 Canada. This is the address for their practice at the (G.I.R.I.) GI Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.